43 results on '"Seregni A."'
Search Results
2. Lutetium [177Lu]-DOTA-TATE in gastroenteropancreatic-neuroendocrine tumours: rationale, design and baseline characteristics of the Italian prospective observational (REAL-LU) study
3. Designing Virtual Coaching Solutions: Design and Evaluation of a Digital Health Intervention for Rehabilitation
4. Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group
5. Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2
6. Author Correction: Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT
7. FAP expression in alpha cells of Langherhans insulae—implications for FAPI radiopharmaceuticals’ use
8. Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib
9. Nanoemulsion Improves the Neuroprotective Effects of Curcumin in an Experimental Model of Parkinson’s Disease
10. Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand?
11. Long-term results of suppressing thyroid-stimulating hormone during radiotherapy to prevent primary hypothyroidism in medulloblastoma/PNET and Hodgkin lymphoma: a prospective cohort study
12. Radioembolization of hepatocarcinoma with 90Y glass microspheres: treatment optimization using the dose-toxicity relationship
13. Application of FLIC model to predict adverse events onset in neuroendocrine tumors treated with PRRT
14. Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units
15. Multimodal therapy of advanced differentiated thyroid cancer, with emphasis on the role of radioiodine
16. Riscontro incidentale di ipercaptazione surrenalica alla PET/TC: significato e algoritmo diagnostico
17. Disordered zero-index metamaterials based on metal-induced crystallization
18. Peptide receptor radionuclide therapy after NETTER-1 clinical trial: what should not be left behind
19. CT, [18F]FDG-PET/CT and clinical findings before and during early Covid-19 onset in a patient affected by vascular tumour
20. Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle
21. Long-term safety of growth hormone replacement therapy after childhood medulloblastoma and PNET: it is time to set aside old concerns
22. Sleep-like cortical OFF-periods disrupt causality and complexity in the brain of unresponsive wakefulness syndrome patients
23. Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology
24. Cromogranina A e peptidi derivati: fisiopatologia e importanza clinica
25. Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy
26. Multiagent imaging of liver tumors with reference to intra-arterial radioembolization
27. Is the risk of primary hyperparathyroidism increased in patients with untreated breast cancer?
28. Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma
29. Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®)
30. Prognostic Value of Circulating Tumor Markers in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
31. Incident pain and analgesic consumption decrease after samarium infusion: a pilot study
32. Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion
33. 90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas
34. Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells
35. Circulating tumour markers in breast cancer
36. Lack of NO formation is involved in the vasodilative response to contrast media
37. Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation
38. Radionuclide imaging of neuroendocrine tumours: biological basis and diagnostic results
39. Can bone metabolism markers be adopted as an alternative to scintigraphic imaging in monitoring bone metastases from breast cancer?
40. Comparison of three different methods for radiolabelling human activated T lymphocytes
41. Effects of Treatment with Verapamil SR and Captopril on the Lipid Profile of Hypertensive Patients
42. Synthesis and sintering of Ce1-xGdxO2-x/2 nanopowders via chemical routes.
43. Book reviews
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.